Zentalis Pharmaceuticals (ZNTL) Operating Margin (2024)
Zentalis Pharmaceuticals (ZNTL) recorded quarterly Operating Margin of 185.55% in Q4 2024, down 203.9% quarter-over-quarter from 61.06% in Q1 2024.
Zentalis Pharmaceuticals (ZNTL) Operating Margin (2024) Analysis & Trends
Zentalis Pharmaceuticals' Operating Margin history runs 1 years deep, the most recent figure standing at 185.55% for Q4 2024.
- In Q4 2024, Operating Margin changed N/A year-over-year to 185.55%; the TTM figure through Sep 2025 stood at 615.16% (down 9922.0% YoY), while the FY2024 annual figure was 283.57%, changed N/A from the prior year.
- Operating Margin was 185.55% for Q4 2024 at Zentalis Pharmaceuticals, down from 61.06% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 61.06% in Q1 2024 to a low of 185.55% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Zentalis Pharmaceuticals | 264.90 Mn | 264.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -185.55% |
| Mar 31, 2024 | -61.06% |